Company page

Definium Therapeutics, Inc.

Definium Therapeutics, Inc. (DFTX) is a public company based in America with a market capitalization of approximately $2.67 billion. The company focuses on developing innovative therapeutic solutions. As a publicly traded entity, it is subject to regulatory oversight and provides transparency to its investors.